脂肪性肝病及其临床亚型与不良围产期结局:妊娠期脂肪肝前瞻性研究
该前瞻性研究在1194名妊娠个体孕中期超声筛查中评估脂肪性肝病(SLD)患病率及亚型对妊娠结局的独立影响。SLD患病率为19.8%(97%既往未诊断),其中87%符合MASLD标准;SLD与妊娠期高血压和极早产独立相关,2/3级SLD与妊娠期糖尿病相关,瘦型SLD与小于胎龄儿相关。
要点
- 孕中期超声筛查SLD患病率19.8%,绝大多数既往未诊断。
- SLD与妊娠期高血压(OR 1.52)和极早产(OR 3.95)独立相关。
- 瘦型SLD与小于胎龄儿独立相关(OR 3.54)。
核心结论
- 妊娠期MASLD在既往未诊断个体中常见,SLD及其亚型与特定不良围产期结局独立相关。
研究设计与样本
- 前瞻性筛查研究,纳入1194名妊娠个体,孕中期胎儿解剖扫描时行肝脏超声评估SLD。
主要发现
- 237名(19.8%)检出SLD,其中97%既往无SLD诊断,87%符合MASLD标准。
- SLD与妊娠期高血压独立相关(OR 1.52;95%CI 1.01-2.26)。
- SLD与极早产独立相关(OR 3.95;95%CI 1.10-14.17)。
- 2/3级(中重度)SLD与妊娠期糖尿病独立相关(OR 2.37;95%CI 1.06-4.96)。
- 瘦型SLD(BMI≤25,亚洲人≤23 kg/m2)与小于胎龄儿独立相关(OR 3.54;95%CI 1.33-8.52)。
关键数值与推荐
- SLD诊断基于肝脏超声,亚型依据更新命名标准划分。
- 瘦型SLD定义:BMI≤25 kg/m2(亚洲人≤23 kg/m2)。
- 未发现SLD与子痫前期显著相关。
临床怎么用
- 对孕中期个体考虑超声筛查SLD,尤其关注既往未诊断者。
- 根据SLD存在及亚型(MASLD、瘦型SLD、中重度SLD)进行个体化咨询和妊娠管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Retrospective global data suggested a possible association of hepatic steatosis with adverse pregnancy outcomes. We sought to prospectively determine the prevalence of steatotic liver disease (SLD) using updated nomenclature and the independent influence of clinically relevant subtypes including metabolic dysfunction-associated steatotic liver disease (MASLD) and lean SLD on pregnancy outcomes. METHODS: Using a large prospective screening study of pregnant individuals, we identified SLD prevalence and the clinical subtypes based on updated SLD nomenclature and determined the independent influence of SLD and subtypes on pregnancy and neonatal outcomes. RESULTS: A total of 1194 pregnant individuals were evaluated for SLD with liver ultrasound at time of second trimester fetal anatomy scan. Among these individuals, 237 (19.8%) were found to have SLD (97% of whom had no prior diagnosis of SLD), of whom 87% met MASLD criteria. Independent associations were identified between SLD with gestational hypertension (odds ratio [OR], 1.52; 95% confidence interval [CI], 1.01-2.26) and very preterm delivery (OR, 3.95; 95% CI, 1.10-14.17); and between grade 2/3 (moderate to severe) SLD with gestational diabetes (OR, 2.37; 95% CI, 1.06-4.96); and lean SLD (body mass index ≤25/(≤23 if Asian) kg/m2 with small for gestational age neonates (OR, 3.54; 95% CI, 1.33-8.52). There were no significant associations with preeclampsia. CONCLUSIONS: MASLD was frequent among previously undiagnosed individuals during pregnancy. Individualized counseling and pregnancy management based on presence and SLD subtype may aid in optimizing pregnancy outcomes.
引用
- Kushner T, Meislin R, Katzenstein C, et al. Steatotic Liver Disease, Clinical Subtypes, and Adverse Perinatal Outcomes: The Prospective Fatty Liver in Pregnancy Study. Clin Gastroenterol Hepatol. 2026. PMID: 42019865. doi:10.1016/j.cgh.2026.04.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。